Tenapanor Receives Approval in China: A New Treatment Option for Hyperphosphatemia

Ardelyx Receives $5 Million Milestone Payment from Fosun Pharma In a recent development, biotechnology company Ardelyx, Inc. announced that it has received a $5 million milestone payment from its collaboration partner, Fosun Pharma, following the U.S. Food and Drug Administration (FDA) approval of Tenapanor for the treatment of hyperphosphatemia in patients with chronic kidney disease…

Read More

“Unleashing the Power of Lockheed Martin: A Recap of LMT’s Presence at the Cowen 46th Annual Aerospace and Defense Conference”

Welcome to the Lockheed Martin Corporation Blog Post! Lockheed Martin Takes Center Stage at TD Cowen 46th Annual Aerospace & Defense Conference On February 13, 2025, at 8:30 AM ET, Lockheed Martin Corporation (NYSE:LMT) made a splash at the TD Cowen 46th Annual Aerospace & Defense Conference. The company’s Chief Financial Officer, Jay Malave, took…

Read More

Important Reminder for Applied Therapeutics, Inc. Shareholders: Upcoming Lead Plaintiff Deadline on February 18, 2025 – The Gross Law Firm Offers Guidance

Important Notice for Applied Therapeutics, Inc. (APLT) Shareholders: Potential Class Action Lawsuit New York, NY – In a recent press release, The Gross Law Firm announced that they are investigating potential securities fraud claims on behalf of shareholders of Applied Therapeutics, Inc. (APLT). The investigation focuses on the period between January 1, 2023, and November…

Read More

Leviathan Gold’s Major Acquisition: New Mineral Exploration Land in Bosnia and Herzegovina or Leviathan Gold Finalizes Deal for Extensive Mineral Exploration Territory in Bosnia-Herzegovina

Leviathan Gold’s Acquisition of Foca Metals Corp.: A Game-Changer in the Mining Industry On February 10, 2025, Leviathan Gold Ltd. (Leviathan or the Company), a Canadian-based mining company trading on the TSXV and Germany’s Börse Stuttgart under the symbols LVX and 0GP, respectively, announced a significant acquisition. Leviathan entered into a share exchange agreement with…

Read More

Revolutionizing Treatment for Early-Stage Choroidal Melanoma: Aura Biosciences’ Bel-sar Shows Promising Results in Phase 2 End-of-Study Report

Bel-sar Demonstrated Promising Results for Early-Stage Choroidal Melanoma Aura Biosciences Announces Positive Phase 2 Study Results BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors, revealed exciting news today. The company shared positive Phase 2 end of study results for their drug…

Read More

“Exploring Digital Realty Trust’s Q4 Results: A Mixed Bag of Data and News”

Digital Realty Trust Surpasses Earnings Expectations in Q4 2024 A Major Player in the Data Center Sector Digital Realty Trust, a major player in the data center sector, released its fourth quarter 2024 earnings on February 13, 2025. The company reported earnings that surpassed expectations, reflecting strong operational performance, but faced a revenue shortfall. Strong…

Read More